Among young adults, first ST-segment elevation myocardial infarction (STEMI) in-hospital mortality increased from 2011 to 2022, according to a study published ...

Raised blood pressure remains the leading modifiable risk factor for cardiovascular disease and premature mortality worldwide ...

A new study finds that heart attack deaths in U.S. hospitals are rising in people aged 54 and below, signaling a shift in ...

HealthDay News — Among young adults, first ST-segment elevation myocardial infarction (STEMI) in-hospital mortality increased from 2011 to 2022, according to a study published online February 26 in ...

Ozempic (R) was approved by Health Canada in 2018. Ozempic (R) is indicated for the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control.

PHILADELPHIA, PENNSYLVANIA / / March 2, 2026 / Prolocor, Inc., a healthcare company developing the innovative diagnostic Prolocor pFCG™ test to identify patients at risk of thrombotic events, ...

Cardiovascular disease remains the leading cause of mortality worldwide, necessitating deeper insights into its molecular underpinnings beyond genetic predisposition. Epigenetic modifications, ...

Heart attack death rates rose by 1.2% among adults younger than age 55 who were hospitalized between 2011 and 2022 with a first severe heart attack, according to a February study published in the ...

A new study found that heart attack deaths were up among younger adults, with women more likely than men to die after a first heart attack. According to new research published in a Go Red for Women ...

Individuals with diabetes are susceptible to cardiac dysfunction and heart failure, potentially resulting in mortality. Metabolic disorders frequently occur in patients with diabetes, and diabetes ...

Limited data are available regarding the relative rates, etiology, and long-term prognostic implications of spontaneous myocardial infarction (MI) after percutaneous coronary intervention (PCI) versus ...